• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

赤式-艾芬地尔、苏式-艾芬地尔、赤式-碘艾芬地尔及依立普地尔与σ受体亚型的相互作用。

Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of sigma receptors.

作者信息

Hashimoto K, London E D

机构信息

Neuroimaging and Drug Action Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.

出版信息

Eur J Pharmacol. 1995 Feb 6;273(3):307-10. doi: 10.1016/0014-2999(94)00763-w.

DOI:10.1016/0014-2999(94)00763-w
PMID:7737340
Abstract

Observations of sigma (sigma) receptor heterogeneity have prompted interest in identifying ligands for sigma receptor subtypes. Selective ligands for the sigma-2 are unavailable, but [3H]ifenprodil labels sigma-2 sites. Therefore, isomers and analogues of ifenprodil were compared as potential sigma-2 ligands. Threo-ifenprodil and erythro-ifenprodil had high affinity (Ki congruent to 2 nM) for sigma-2 sites; erythro-iodoifenprodil had moderate affinity (Ki congruent to 46 nM); eliprodil had lowest affinity (Ki congruent to 630 nM). Threo-ifenprodil, which has less affinity for alpha 1-adrenoceptors than erythro-ifenprodil, was slightly more selective than erythro-ifenprodil for sigma-2 sites. These results identify threo-ifenprodil as potentially useful for studies of sigma-2 receptors.

摘要

对σ(西格玛)受体异质性的观察引发了人们对识别σ受体亚型配体的兴趣。目前尚无针对σ-2的选择性配体,但[3H]ifenprodil可标记σ-2位点。因此,比较了ifenprodil的异构体和类似物作为潜在的σ-2配体。苏式ifenprodil和赤式ifenprodil对σ-2位点具有高亲和力(Ki约为2 nM);赤式碘ifenprodil具有中等亲和力(Ki约为46 nM);eliprodil的亲和力最低(Ki约为630 nM)。苏式ifenprodil对α1肾上腺素能受体的亲和力低于赤式ifenprodil,对σ-2位点的选择性略高于赤式ifenprodil。这些结果表明苏式ifenprodil可能对σ-2受体的研究有用。

相似文献

1
Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of sigma receptors.赤式-艾芬地尔、苏式-艾芬地尔、赤式-碘艾芬地尔及依立普地尔与σ受体亚型的相互作用。
Eur J Pharmacol. 1995 Feb 6;273(3):307-10. doi: 10.1016/0014-2999(94)00763-w.
2
Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain.大鼠脑中[3H]ifenprodil与σ受体结合的进一步表征。
Eur J Pharmacol. 1993 May 12;236(1):159-63. doi: 10.1016/0014-2999(93)90241-9.
3
[3H]ifenprodil binding to NMDA receptors in porcine hippocampal brain membranes.[3H]艾芬地尔与猪脑海马体膜中NMDA受体的结合
Eur J Pharmacol. 2000 Apr 14;394(2-3):211-9. doi: 10.1016/s0014-2999(00)00084-4.
4
Heterocyclic amino alcohols related to ifenprodil as sigma receptor ligands: binding and conformational analyses.
Eur J Pharmacol. 1994 Oct 14;269(2):193-200. doi: 10.1016/0922-4106(94)90086-8.
5
Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.利用[3H]TCP和[3H]ifenprodil与大鼠脑膜结合的方法,将氟哌啶醇和三氟哌啶醇表征为亚型选择性N-甲基-D-天冬氨酸(NMDA)受体拮抗剂。
J Pharmacol Exp Ther. 1997 Feb;280(2):584-92.
6
RLH-033, a novel, potent and selective ligand for the sigma 1 recognition site.RLH-033,一种新型、强效且选择性的西格玛1识别位点配体。
Eur J Pharmacol. 1994 Dec 12;271(1):235-6. doi: 10.1016/0014-2999(94)90286-0.
7
Further characterization of [3H]ifenprodil binding in rat brain.
Eur J Pharmacol. 1994 Jan 1;266(1):67-77. doi: 10.1016/0922-4106(94)90211-9.
8
Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.西格玛位点配体对N-甲基-D-天冬氨酸受体的拮抗作用:效力、亚型选择性及抑制机制
J Pharmacol Exp Ther. 1997 Jul;282(1):326-38.
9
Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.大鼠肝脏和肾脏含有高密度的σ1和σ2受体:通过配体结合和光亲和标记进行表征。
Eur J Pharmacol. 1994 Jun 15;268(1):9-18. doi: 10.1016/0922-4106(94)90115-5.
10
High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase.西格玛1结合位点对甾醇异构化抑制剂的高亲和力:与酵母甾醇C8-C7异构酶存在药理学关系的证据。
Br J Pharmacol. 1997 May;121(1):1-6. doi: 10.1038/sj.bjp.0701079.

引用本文的文献

1
Structural insights into NMDA receptor pharmacology.结构洞察 NMDA 受体药理学。
Biochem Soc Trans. 2023 Aug 31;51(4):1713-1731. doi: 10.1042/BST20230122.
2
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.针对西格玛受体治疗神经退行性和神经发育障碍。
CNS Drugs. 2023 May;37(5):399-440. doi: 10.1007/s40263-023-01007-6. Epub 2023 May 11.
3
Inhibitory effects of N-methyl-D-aspartate (NMDA) and α-adrenergic receptor antagonist ifenprodil on human Kv1.5 channel.N-甲基-D-天冬氨酸(NMDA)和α-肾上腺素能受体拮抗剂ifenprodil 对人 Kv1.5 通道的抑制作用。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3149-3161. doi: 10.1007/s00210-023-02521-6. Epub 2023 May 11.
4
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.谷氨酸受体离子通道的结构、功能和药理学。
Pharmacol Rev. 2021 Oct;73(4):298-487. doi: 10.1124/pharmrev.120.000131.
5
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.重新利用中枢神经系统药物治疗 COVID-19 感染:靶向 sigma-1 受体。
Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):249-258. doi: 10.1007/s00406-020-01231-x. Epub 2021 Jan 5.
6
Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?将西格玛-1受体配体重新用于治疗新冠病毒肺炎?
Front Pharmacol. 2020 Nov 9;11:582310. doi: 10.3389/fphar.2020.582310. eCollection 2020.
7
Evaluation of C-NR2B-SMe and Its Enantiomers as PET Radioligands for Imaging the NR2B Subunit Within the NMDA Receptor Complex in Rats.评价 C-NR2B-SMe 及其对映异构体作为 NMDA 受体复合物中 NR2B 亚基在大鼠中的 PET 配体。
J Nucl Med. 2020 Aug;61(8):1212-1220. doi: 10.2967/jnumed.119.235143. Epub 2020 Jan 10.
8
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors.ifenprodil 增强神经生长因子诱导的 PC12 细胞突起生长:sigma-1 和 IP3 受体的作用。
PLoS One. 2012;7(5):e37989. doi: 10.1371/journal.pone.0037989. Epub 2012 May 24.
9
Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators.描绘 GluN2B 选择性 N-甲基-D-天冬氨酸受体负变构调节剂的结合情况。
Mol Pharmacol. 2012 Aug;82(2):344-59. doi: 10.1124/mol.112.078568. Epub 2012 May 17.
10
Pharmacology and therapeutic potential of sigma(1) receptor ligands.sigma(1) 受体配体的药理学和治疗潜力。
Curr Neuropharmacol. 2008 Dec;6(4):344-66. doi: 10.2174/157015908787386113.